Effects of antifungal drugs and delivery vehicles on morphology and proliferation of equine corneal keratocytes in vitro

Rachel L. Mathes Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Rachel L. Mathes in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Adrian J. Reber Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Adrian J. Reber in
Current site
Google Scholar
PubMed
Close
 PhD
,
David J. Hurley Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by David J. Hurley in
Current site
Google Scholar
PubMed
Close
 PhD
, and
Ursula M. Dietrich Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA 30602.

Search for other papers by Ursula M. Dietrich in
Current site
Google Scholar
PubMed
Close
 Dr Med Vet

Abstract

Objective—To evaluate the effects of topical antifungal drugs and delivery vehicles on the morphology and proliferation rate of cultured equine keratocytes.

Study Population—16 corneas obtained from 8 apparently ophthalmologically normal horses < 0.5 hours after euthanasia for reasons unrelated to the study.

Procedures—Primary cultures of equine keratocytes were obtained from corneal stroma and were exposed to several concentrations of 3 commonly used, topically applied antifungals: natamycin, itraconazole, and miconazole. In addition, effects of drug delivery vehicles DMSO, benzalkonium chloride, and carboxymethylcellulose and a combination vehicle composed of polyethylene glycol, methylparaben, and propylparaben were also evaluated. Morphological changes and cellular proliferation were assessed 24, 48, and 72 hours after application.

Results—At the highest concentrations tested, all antifungals caused marked cellular morphological changes and inhibited proliferation. At low concentrations, natamycin and miconazole induced rounding, shrinking, and detaching of the cells with inhibition of cellular proliferation. Natamycin caused the most severe cellular changes. Itraconazole, at the low concentrations, caused minimal morphological changes and had a minimal effect on proliferation. All vehicles tested had significantly less effects on cellular morphology and proliferation when compared with the antifungals, except for the combination vehicle, which caused severe morphological changes and inhibited proliferation, even at low concentrations. The DMSO had minimal effects on cellular morphology and proliferation, even at high concentrations.

Conclusions and Clinical Relevance—Itraconazole had significantly less cytotoxic effects on equine keratocytes in culture than did natamycin or miconazole. Natamycin had severe cytotoxic effects in vitro.

Abstract

Objective—To evaluate the effects of topical antifungal drugs and delivery vehicles on the morphology and proliferation rate of cultured equine keratocytes.

Study Population—16 corneas obtained from 8 apparently ophthalmologically normal horses < 0.5 hours after euthanasia for reasons unrelated to the study.

Procedures—Primary cultures of equine keratocytes were obtained from corneal stroma and were exposed to several concentrations of 3 commonly used, topically applied antifungals: natamycin, itraconazole, and miconazole. In addition, effects of drug delivery vehicles DMSO, benzalkonium chloride, and carboxymethylcellulose and a combination vehicle composed of polyethylene glycol, methylparaben, and propylparaben were also evaluated. Morphological changes and cellular proliferation were assessed 24, 48, and 72 hours after application.

Results—At the highest concentrations tested, all antifungals caused marked cellular morphological changes and inhibited proliferation. At low concentrations, natamycin and miconazole induced rounding, shrinking, and detaching of the cells with inhibition of cellular proliferation. Natamycin caused the most severe cellular changes. Itraconazole, at the low concentrations, caused minimal morphological changes and had a minimal effect on proliferation. All vehicles tested had significantly less effects on cellular morphology and proliferation when compared with the antifungals, except for the combination vehicle, which caused severe morphological changes and inhibited proliferation, even at low concentrations. The DMSO had minimal effects on cellular morphology and proliferation, even at high concentrations.

Conclusions and Clinical Relevance—Itraconazole had significantly less cytotoxic effects on equine keratocytes in culture than did natamycin or miconazole. Natamycin had severe cytotoxic effects in vitro.

Contributor Notes

Supported by the University of Georgia Veterinary Ophthalmology Research Fund.

Address correspondence to Dr. Mathes (rmathes@uga.edu).
  • 1.

    Barton M. Equine keratomycosis. Compend Contin Educ Pract Vet 1992;14:936944.

  • 2.

    Gaarder JERebhun WCBall MA, et al.Clinical appearances, healing patterns, risk factors, and outcomes of horses with fungal keratitis: 53 cases (1978–1996). J Am Vet Med Assoc 1998;213:105112.

    • Search Google Scholar
    • Export Citation
  • 3.

    Andrew SEBrooks DESmith PJ, et al.Equine ulcerative keratomycosis: visual outcome and ocular survival in 39 cases (1987–1996). Equine Vet J 1998;30:109116.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Samuelson DAAndresen TLGwin RM. Conjunctival fungal flora in horses, cattle, dogs, and cats. J Am Vet Med Assoc 1984;184:12401242.

  • 5.

    Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 2003;16:730797.

  • 6.

    Ledbetter ECPatten VHScarlett JM, et al.In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987–2006). J Am Vet Med Assoc 2007;231:10861091.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Rosa MCrdozo LMda Silva Pereira J, et al.Fungal flora of normal eyes of healthy horses from the State of Rio de Janeiro, Brazil. Vet Ophthalmol 2003;6:5155.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Brooks DEAndrew SEDenis H, et al.Rose bengal positive epithelial microerosions as a manifestation of equine keratomycosis. Vet Ophthalmol 2000;3:8386.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Andrew SENguyen AJones GL, et al.Seasonal effects on the aerobic bacterial and fungal conjunctival flora of normal thoroughbred brood mares in Florida. Vet Ophthalmol 2003;6:4550.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Grahn BWolfer JKeller C, et al.Equine keratomycosis: clinical and laboratory findings in 23 cases. Prog Vet Comp Ophthalmol 1993;3:27.

    • Search Google Scholar
    • Export Citation
  • 11.

    McLaughlin SAGilger BCWhitley RD. Infectious keratitis in horses: evaluation and management. Compend Contin Educ Pract Vet 1992;14:372379.

    • Search Google Scholar
    • Export Citation
  • 12.

    Brooks DE. Inflammatory stromal keratopathies: medical management of stromal keratomalacia, stromal abscesses, eosinophilic keratitis, and band keratopathy in the horse. Vet Clin North Am Equine Pract 2004;20:345360.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Strubbe DTBrooks DESchultz GS, et al.Evaluation of tear film proteinases in horses with ulcerative keratitis. Vet Ophthalmol 2000;3:111119.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Ollivier FJGilger BCBarrie KP, et al.Proteinases of the cornea and preocular tear film. Vet Ophthalmol 2007;10:199206.

  • 15.

    Monod MCapoccia SLéchenne B, et al.Secreted proteases from pathogenic fungi. Int J Med Microbiol 2002;292:405419.

  • 16.

    Tomee JFKauffman HF. Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 2000;30:476484.

  • 17.

    Gelatt KN. Veterinary ophthalmology. 4th ed. Ames, Iowa: Blackwell Publishing, 2007.

  • 18.

    Gilger BC. Equine ophthalmology. St Louis: Elsevier Saunders, 2005.

  • 19.

    Bistner SIRiis RC. Clinical aspects of mycotic keratitis in the horse. Cornell Vet 1979;69:364374.

  • 20.

    Scotty NC. Equine keratomycosis. Clin Tech Equine Pract 2005;4:2936.

  • 21.

    Ford MM. Antifungals and their use in veterinary ophthalmology. Vet Clin North Am Small Anim Pract 2004;34:669691.

  • 22.

    Xu KPLi XFYu FS. Corneal organ culture model for assessing epithelial responses to surfactants. Toxicol Sci 2000;58:306314.

  • 23.

    Colitz CMLatimer FGCheng H, et al.Pharmacokinetics of voriconazole following intravenous and oral administration and body fluid concentrations of voriconazole following repeated oral administration in horses. Am J Vet Res 2007;68:11151121.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Ball MARebhun WCTrepanier L, et al.Corneal concentrations and preliminary toxicological evaluation of an itraconazole/dimethyl sulphoxide ophthalmic ointment. J Vet Pharmacol Ther 1997;20:100104.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Ball MARebhun WCGaarder JE, et al.Evaluation of itraconazole-dimethyl sulfoxide ointment for treatment of keratomycosis in nine horses. J Am Vet Med Assoc 1997;211:199203.

    • Search Google Scholar
    • Export Citation
  • 26.

    Brooks DEAndrew SEDillavou CL, et al.Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis. Am J Vet Res 1998;59:138142.

    • Search Google Scholar
    • Export Citation
  • 27.

    Sansom JFeatherstone HBarnett KC. Keratomycosis in six horses in the United Kingdom. Vet Rec 2005;156:1317.

  • 28.

    Weinstein WLMoore PASanchez S, et al.In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis. Am J Vet Res 2006;67:562568.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29.

    Malmberg GJLupo R. Compounding in veterinary ophthalmology. Vet Clin North Am Small Anim Pract 2004;34:825838.

  • 30.

    Foster CSStefanyszyn M. Intraocular penetration of miconazole in rabbits. Arch Ophthalmol 1979;97:17031706.

  • 31.

    Foster CS. Miconazole therapy for keratomycosis. Am J Ophthalmol 1981;91:622629.

  • 32.

    Clode ABDavis JLSalmon J, et al.Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. Am J Vet Res 2006;67:296301.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33.

    Mathes RLDietrich UMKrunkosky TM, et al.Establishing a reproducible method for the culture of primary equine corneal cells. Vet Ophthalmol 2009;12 (suppl 1):4149.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Hendrix DVStuffle JLCox SK. Pharmacokinetics of topically applied ciprofloxacin in equine tears. Vet Ophthalmol 2007;10:344347.

  • 35.

    Myrna KEHerring IP. Constant rate infusion for topical ocular delivery in horses: a pilot study. Vet Ophthalmol 2006;9:15.

  • 36.

    Baeyens VGurny R. Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations. Pharm Acta Helv 1997;72:191202.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Zhang JWang LGao C, et al.Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits. J Ocul Pharmacol Ther 2008;24:501506.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Wilson CG. Topical drug delivery in the eye. Exp Eye Res 2004;78:737743.

  • 39.

    Scotty NCBrooks DESchuman Rose CD. In vitro efficacy of an ophthalmic drug combination against corneal pathogens of horses. Am J Vet Res 2008;69:101107.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Haber MCao ZPanjwani N, et al.Effects of growth factors (EGF, PDGF-BB and TGF-beta 1) on cultured equine epithelial cells and keratocytes: implications for wound healing. Vet Ophthalmol 2003;6:211217.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Werner ABraun MKietzmann M. Isolation and cultivation of canine corneal cells for in vitro studies on the antiinflammatory effects of dexamethasone. Vet Ophthalmol 2008;11:6774.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42.

    O'Day DMRay WAHead WS, et al.Influence of the corneal epithelium on the efficacy of topical antifungal agents. Invest Ophthalmol Vis Sci 1984;25:855859.

    • Search Google Scholar
    • Export Citation
  • 43.

    Hendrix DVWard DABarnhill MA. Effects of anti-inflammatory drugs and preservatives on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture. Vet Ophthalmol 2002;5:127135.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement